Transpupillary thermotherapy for age-related macular degeneration
Guidance issued
Number: IPG58
Summary
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Transpupillary thermotherapy for age-related macular degeneration.
Description
Age-related macular degeneration is the commonest cause of irreversible blindness in developed countries. Transpupillary thermotherapy uses laser energy to coagulate vessels in the wet form of macular degeneration and is intended to alter the disease process and preserve vision.
OPCS code:
Details
Topic area:
Eye
Surgical procedures
Surgical procedures
Specialist advice has been sought from:
Royal College of Ophthalmologists
Date notified to NICE:
01 April 2002
Guidance issue date:
23 June 2004
Contact details:
Project manager (for general enquiries or comments)
(for general enquiries or comments)
(for general enquiries or comments)
Contact Address:
Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA
